EP3210973
Heteróarýlefnasambönd til að meðhöndla augnsjúkdóma
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
22.10.2015EP published:
2.12.2020EP application number:
15853151.7
EP translation filed:
2.2.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
21.10.2035Expiry date:
21.10.2023
Title:
HETEROARYL COMPOUNDS FOR THE TREATMENT OF OPHTHALMIC DISEASES
Timeline
Today
22.10.2015EP application
2.12.2020EP Publication
2.2.2021Translation submitted
15.2.2021Registration published
21.10.2023Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP
Inventor
Name:
BANNO, YoshihiroAddress:
Fujisawa-shi Kanagawa 251-0012, JP
Name:
KAMAURA, MasahiroAddress:
Fujisawa-shi Kanagawa 251-0012, JP
Name:
TAKAMI, KazuakiAddress:
Fujisawa-shi Kanagawa 251-0012, JP
Name:
FUKUDA, KoichiroAddress:
Fujisawa-shi Kanagawa 251-0012, JP
Name:
SASAKI, ShigekazuAddress:
Fujisawa-shi Kanagawa 251-0012, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2014217770Date:
24.10.2014Country:
JP
Classification
Categories:
C07D 213/65, A61K 31/415, A61K 31/421, A61K 31/4418, A61K 31/505, A61P 27/02
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 1.10.2021
Expires: 21.10.2022
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 3.10.2022
Expires: 21.10.2023
Payer: Patice ehf.